AXON Stock Analysis 2026: 5 Critical Reasons to Avoid It Now
↓ Download the full research PDF · free, no email required
AXON Stock Analysis 2026: 5 Critical Reasons to Avoid It Now
Key takeaways
- Rating: AVOID at $438.43. A trailing P/E near 183 prices in flawless execution with no margin of safety.
- WP Score: 26/100. Our bear-case model, using conservative assumptions, shows a hypothetical 9% annual loss and fails our wealth preservation threshold.
- Base case model implies about 16.8% downside to the $365 hypothetical fair value, with only a 4.2% annualized model return.
- Biggest risk is multiple compression. The stock already fell 50.5% from its $885.92 high.
- Verdict: AVOID for preservation capital. A cash yield near 4% may be preferable while waiting for a price below $300 or a free cash flow inflection.
Executive summary
Axon Enterprise operates a durable public-safety ecosystem with 35% annual recurring revenue growth and 123% net revenue retention. At $438.43, however, the stock earns a 26/100 Wealth Preservation Score, a negative margin of safety of roughly 16.8% against the $365 hypothetical fair value, and a model base-case total return of only 4.2% annually, below our 7% hurdle. This is an editorial model assessment, not personalized investment advice, and all scenario returns and fair values in this note are hypothetical estimates with disclosed assumptions.
Table of Contents
- AXON Stock Analysis: Business Quality and Moat
- AXON Stock Analysis: Financial Fortress Falls Short
- The Dividend Reality: No Income Cushion
- AXON Stock Analysis: The Valuation Problem
- AXON Stock Analysis: Scenario Returns Below the Hurdle
- Risk Assessment: Why the Downside Dominates
- Peer Comparison: Motorola Offers What Axon Lacks
- Key Business Drivers to Monitor
- Frequently Asked Questions
Your subscription could not be saved. Please try again.
Check your inbox!
AXON Stock Analysis: Business Quality and Moat
Our AXON stock analysis begins with the quality of the franchise, because multiple compression punishes even high-quality operators when the entry price is wrong. Axon runs a two-part model. Hardware includes TASER conducted energy weapons, body-worn cameras, and in-car fleet cameras. Software includes Axon Cloud, Evidence.com, records management, dispatch, and AI tools such as Draft One and Axon Vision.
The devices feed data into a cloud ecosystem with high switching costs. Once an agency stores evidence and footage inside Axon Cloud, migration to a rival means retraining officers and risking evidentiary continuity. That stickiness shows up in the disclosed retention metrics.
Annual recurring revenue reached $1.3 billion in fiscal 2025, up 35% year over year, according to the company’s fiscal 2025 earnings release. Net revenue retention sits at 123%, meaning existing customers expand their spend rather than renew flat. Future contracted bookings reached $14.4 billion, up 43%. That booking visibility separates Axon from a generic hardware vendor.
The company expanded beyond local law enforcement into federal agencies, corrections, international police, enterprise security, and national security. Management quotes a total addressable market of $129 billion in 2025, which is a company estimate, not independently verified. The runway for double-digit revenue growth remains long, but the estimate’s reliability depends on how much of that market Axon can realistically convert.
The core customer remains U.S. law enforcement. Municipal, state, and federal budget cycles still determine large orders. Premium pricing creates an opening for lower-cost rivals if product innovation stalls. Motorola Solutions is the credible competitor because it can bundle video products with incumbent radio networks agencies already own. Digital Ally and Wrap Technologies are too small and financially weak to matter.
New product execution risk is real. Complex software rollouts at public agencies rarely go smoothly. A delay in Draft One adoption or a missed federal contract would not destroy the franchise, but it would pressure the stock because the valuation prices in flawless execution.
The quality verdict is favorable for the business and acceptable for the franchise. In the capital preservation framework, a premium business at a full price does not beat a discount business at a fair price over ten years. Axon is a high-quality operator trading at a price that leaves no room for error.
AXON Stock Analysis: Financial Fortress Falls Short
Solvency is no longer the question. Revenue grew from $681 million in fiscal 2020 to $2.78 billion in fiscal 2025, a 32% compound annual growth rate. TTM revenue reached $3.22 billion. Gross margin held near 59.7% in fiscal 2025, confirming the software mix is real.
Profitability weakened. Fiscal 2025 operating income fell to minus $62 million from positive $59 million in fiscal 2024. Net income dropped 67% from $377 million to $125 million. EPS fell from $4.98 to $1.60. TTM figures from June 30, 2026 show a partial recovery with net income of $199.3 million and an operating margin of only 5.17%.
Non-GAAP bulls focus on a full-year adjusted EBITDA margin of 25.5% for fiscal 2025. Applied to $2.78 billion revenue, that margin equates to roughly $709 million adjusted EBITDA. GAAP results tell a different story. Stock-based compensation, acquisition spend, and working capital are financing growth, not a deep cash generative engine. The company has not proven itself as a consistent free cash flow compounder at a level that would support a 180x trailing multiple.
Free cash flow is positive but thin. Operating cash flow was $408.3 million in fiscal 2024 and $211.3 million in fiscal 2025. Capital expenditures were $78.8 million and $136.3 million respectively. That implies free cash flow near $329 million in 2024 and only $75 million in 2025. Q2 2026 free cash flow barely broke even.
The balance sheet is adequate, not a fortress. Total assets rose to $7.0 billion and equity sits near $3.2 billion. The company carries 0.50% convertible senior notes due 2027. The low coupon is cheap capital, and no going-concern warning appears. But fiscal 2025 GAAP operating income was negative, so interest coverage was not comfortable on a GAAP basis.
A stress test for a 30% revenue decline over two years shows the problem. Recurring software revenue cushions the blow because contracts renew. Hardware device revenue falls sharply in a municipal budget freeze. Operating leverage reverses, GAAP operating losses widen, and free cash flow turns negative. The equity would not protect principal in that scenario.
The Dividend Reality: No Income Cushion
Axon pays no dividend. The dividend-based wealth preservation sub-scores and the income cushion benefit do not apply. Total return depends entirely on price appreciation. That structural fact raises the downside risk for preservation capital with a 0.0% dividend yield and no expected dividend growth.
AXON Stock Analysis: The Valuation Problem
At $438.43 the trailing P/E sits near 183 on TTM EPS of $2.40. Consensus 2026 EPS near $4.17 puts the forward P/E near 105. A lower estimate of $3.57 from Simply Wall St puts the forward P/E near 123. Either number is expensive for an asset whose GAAP profitability is still thin.
The company trades at 11.1x trailing sales on a $35.6 billion market value and $3.22 billion TTM revenue. Price-to-book runs from 12.5x to 14.8x. The EBITDA picture requires reconciliation. Fiscal 2025 adjusted EBITDA margin of 25.5% equals roughly $709 million adjusted EBITDA on $2.78 billion revenue. By contrast, TTM GAAP EBITDA of approximately $165.1 million, which includes stock-based compensation and acquisition charges, implies a multiple above 200x. That GAAP figure is depressed by adjustments, and we do not use either single-period EBITDA multiple as our valuation basis.
History makes it starker. The five-year average P/E is 103.17 per StockAnalysis. The current trailing P/E of 183 sits roughly 77% above that average. On relative history, AXON is expensive even after falling 50% from its high. We apply the same discipline to high-multiple growth names like NVIDIA.
The normalized earnings approach is a model, not a forecast. Averaging fiscal 2021 through fiscal 2025 net margins gives about 7.9%. Applying that margin to next-twelve-month revenue near $3.66 billion yields normalized net income near $289 million and normalized EPS near $3.56. At the historical average P/E of 103.17, the hypothetical fair value is approximately $365. The current price stands about 20.1% above that model estimate, which equates to roughly 16.8% downside from today’s quote.
Consensus targets run from $652 to $739, implying 49% to 69% upside. Those targets embed continued 30% revenue growth, margin expansion into the mid-teens, and a premium terminal multiple. The market required more on August 5, 2026, when shares fell 14.3% despite a revenue and adjusted EPS beat. At 183x trailing earnings, beating the top line is not enough.
AXON Stock Analysis: Scenario Returns Below the Hurdle
The base case is a hypothetical scenario using 2036 EPS of $22.00 and a 30x terminal multiple, implying about 25% annual EPS growth. The 2036 price target is $660, a 4.2% annual total return under these assumptions. That sits below the 7% hurdle required to justify equity risk.
The bear case assumes a growth stall and compression to 20x. EPS reaches $8.50 in 2036, about 13.5% annual growth. The target is $170, a negative 9.0% annual return over ten years. The bull case uses 2036 EPS of $50.00 and a 35x terminal multiple for a $1,750 target and 14.9% annual return.
| Scenario | 2036 EPS | Terminal P/E | 2036 Target | 10Y CAGR | Weight |
|---|---|---|---|---|---|
| Bear | $8.50 | 20x | $170 | -9.0% | 25% |
| Base | $22.00 | 30x | $660 | 4.2% | 50% |
| Bull | $50.00 | 35x | $1,750 | 14.9% | 25% |
Important: These scenario figures are hypothetical model outputs, not forecasts. They depend on assumptions for revenue growth, margins, terminal multiples, and discount rates. Actual results may differ materially. Forward-looking statements are not reliable indicators of future performance.
The bear case is the central problem for capital preservation. It does not require a failed product. It only requires a moderate recession, slower government spending, and a de-rating from 183x toward a still-premium software multiple. The stock has already demonstrated a 50.5% drawdown from its high. The bear target of $170 would be another 61% decline from today.
The base case also fails the hurdle despite a $660 target 51% above the current price. $660 received ten years from now is a 4.2% annual return, not a 51% annual return. The probability-weighted expected return of 3.6% is a model estimate, not a guaranteed return, and falls below a 4% high-yield savings alternative. The scenario work does not support adding AXON at this price. Similar drawdown math appears in our Texas Pacific Land AVOID note.
Risk Assessment: Why the Downside Dominates
The largest risk is valuation, not the collapse of the franchise. Any stumble becomes a large loss at this multiple. On August 5, 2026 the stock fell 14.3% after Q2 results that beat revenue and adjusted EPS but showed adjusted EPS declining 11% year over year and free cash flow barely positive. The stock has underperformed the market by a wide margin over the past year.
Customer concentration compounds the risk. Axon relies on U.S. law enforcement budgets. Procurement cycles determine the timing of large orders. A slowdown in government spending tempers growth. Premium pricing invites lower-cost competitors if innovation stalls. Motorola can bundle its video offerings with existing radio networks.
Regulatory and litigation risk is real. The fiscal 2025 10-K cites product liability, wrongful death, and personal injury claims. TASER devices face ATF classification and state and federal regulation. Data privacy laws create compliance costs. Antitrust scrutiny appears because Axon dominates its niche. Tariffs and petroleum-based inputs create supply chain exposure.
The accounting risk is underappreciated. GAAP operating income for fiscal 2025 was negative while the company emphasized adjusted EBITDA and non-GAAP net income. Fair-value and impairment risk on the investment book adds another swing factor. Free cash flow deteriorated from $329 million in fiscal 2024 to $75 million in fiscal 2025 and barely broke even in Q2 2026.
Insider selling adds a governance-level caution. The President sold $18 million of stock in March 2026, and a trust sold 34,000 shares for $16.6 million in June 2026, according to SEC Form 4 filings. Joshua Isner sold shares at weighted prices between $561 and $595 per share in August 2026. Those sales occurred above the current price. Insiders are not signaling confidence at $438.
The probability of a greater than 50% permanent loss from the current price is a rough scenario model estimate of 12%, above our 10% threshold. It is not a historical statistic or a guarantee. The business would likely survive a recession. The stock may not recover for five years. Wealth preservation cares about both questions. Analyst consensus remains a Moderate Buy, but consensus targets rarely incorporate the de-rating math that drives permanent loss.
Marketing disclosure: Angelos Moschovakis is a verified eToro Popular Investor. Moschovakis Capital may receive compensation from eToro if you open an account through the profile link. Copy trading is a marketing service, not investment advice, and involves risk. Past performance does not guarantee future results. If you want to follow this research with real capital, you can review the published portfolio on eToro. All investment decisions are yours alone.
Peer Comparison: Motorola Offers What Axon Lacks
Axon grows faster than Motorola Solutions and possesses a stronger cloud software component. Motorola remains the more mature incumbent with the ability to bundle video into existing radio contracts. For a wealth preservation mandate, Motorola typically offers what Axon lacks: a dividend, established free cash flow, and a less extreme multiple.
The peer table below is intentionally sparse because full peer financials are not in the provided research. That does not prevent a ranking. Axon is the growth asset. Motorola is the preservation-oriented incumbent.
| Dimension | AXON | Motorola (MSI) |
|---|---|---|
| Revenue growth | 30-35% YoY | High single digit |
| Net revenue retention | 123% | Not disclosed |
| GAAP operating margin | 5.17% TTM | Higher, mature |
| Dividend | None | Established |
| Valuation | TTM P/E near 183 | Less extreme |
Digital Ally and Wrap Technologies do not warrant deep analysis. They are too small and financially weak to pose a credible threat. The real competition is Motorola. The peer comparison reinforces that Axon is not the wealth preservation asset at this price.
Moschovakis Capital — Quantitative Division
Automated FX Execution: A Separate Return Stream
While this equity position requires patience over a multi-year horizon to reach a fair entry, our FX system operates on a different time horizon entirely. The Quantitative Execution System runs fully automated across FX markets 24/7 with zero manual intervention and a two-year audited track record. It provides an uncorrelated return stream when preservation capital is sidelined waiting for a better entry point.
Key Business Drivers to Monitor
Several drivers determine whether the bull or bear case wins. Annual recurring revenue growth is the first. ARR measures the recurring base that de-risks hardware cyclicality. Current ARR is $1.3 billion, up 35% per the company’s fiscal 2025 earnings release. The bull threshold is quarterly ARR growth above 35%; the bear threshold is below 25%.
Future contracted bookings lead reported revenue. The current level of $14.4 billion is up 43%. Bull requires bookings growth above 40%; bear watches for growth below 30%. Gross margin reflects the software mix shift and pricing power. Current gross margin is 59.7% for fiscal 2025, but Q4 2025 fell 220 basis points to 57.9%. Bull requires above 60%; bear watches below 57%.
Adjusted EBITDA margin is the metric Axon emphasizes. Current level is 25.5% for fiscal 2025, equating to roughly $709 million adjusted EBITDA on $2.78 billion revenue. Bull requires sustained above 25%; bear watches below 20%. Free cash flow is the most important leading indicator. Current fiscal 2025 FCF is about $75 million, barely positive in Q2 2026. Bull requires annual FCF above $200 million; bear watches for two consecutive negative quarters.
The next data point is Q3 2026 earnings, expected November 10, 2026. Insider sales, a price level below $339, a lost incumbent contract to Motorola, or adverse regulatory action would all tilt the case further toward the bear.
Frequently Asked Questions
Is AXON stock a good investment in 2026?
AXON stock is not a good investment for wealth preservation capital at $438.43 in our model assessment. The stock earns a 26/100 WP Score with a hypothetical 4.2% base-case annual return below our 7% hurdle. The bear case model shows a 9% annual loss, and the current price sits about 20.1% above the $365 hypothetical fair value, implying roughly 16.8% downside.
What is Axon Enterprise’s dividend yield?
Axon Enterprise pays no dividend. The dividend yield is 0.0%, so total return depends entirely on price appreciation. Income investors receive no cushion during drawdowns.
Why does our AXON stock analysis rate the shares AVOID at $438.43?
Our AXON stock analysis rates the shares an AVOID because the valuation leaves no margin of safety. The trailing P/E near 183 is roughly 77% above the five-year average, and GAAP profitability remains thin with negative fiscal 2025 operating income. The probability-weighted model expected return of 3.6% fails the required hurdle.
What does our AXON stock analysis estimate as Axon fair value and upside?
The hypothetical fair value is approximately $365 per share, based on a 7.9% normalized net margin and the historical average P/E of 103.17. The current price of $438.43 sits about 20.1% above that model estimate, implying roughly 16.8% downside. Consensus analyst targets of $652 to $739 assume continued 30% growth and a premium multiple that we do not underwrite.
Is Axon overvalued compared to its five-year average P/E?
Yes, Axon is overvalued on relative history. The current trailing P/E near 183 sits roughly 77% above the five-year average of 103.17. Even after a 50.5% drawdown from its 52-week high, the stock remains expensive on every multiple we track, including a depressed TTM GAAP EV/EBITDA above 200x.
For the full AXON stock analysis methodology and our complete institutional framework, including the Wealth Preservation Score engine, explore the equities research library. We rate AXON an AVOID at $438.43 and would revisit the thesis below $300 or after a visible free cash flow inflection. This note is research, not personalized investment advice.
Execution Infrastructure
For the execution of positions discussed in our research, we utilize the following institutional-grade platforms due to their regulatory compliance, liquidity, and reliability.
| Platform | Purpose |
|---|---|
| eToro | Equity execution — regulated, social trading infrastructure |
| Revolut | Multi-currency banking and FX |
| Interactive Brokers | Institutional-grade brokerage |
| Vantage | MT4/MT5 execution |
| Binance | Digital asset infrastructure |
| Hostinger | Web infrastructure |
Risk Disclaimer: Past performance is not indicative of future results. Moschovakis Capital is a technology provider and research publisher, not a licensed financial advisor. Trading and investing in financial instruments involves significant risk of loss. Do not invest more than you can afford to lose. The analysis presented is for informational purposes only and does not constitute personalized investment advice.
eToro Disclaimer: eToro is a multi-asset platform. The value of your investments may go up or down. Your capital is at risk. Copy trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk. eToro USA LLC does not offer CFDs. Do not invest unless you are prepared to lose all the money you invest.
Affiliate Disclosure: Some links on this page are referral links. We may earn a commission at no extra cost to you. This does not influence our analysis or recommendations.
Axon Enterprise, Inc.: the full research PDF
The complete report behind this analysis — DCF model, valuation tables and scoring detail. No email, no form.
Download the PDFPDF · 60.5 KB
Frequently asked questions
Answers below are quoted directly from this analysis, as published on 15 September 2026.
What is the Wealth Preservation Score for Axon Enterprise, Inc.?
Is Axon Enterprise, Inc. a buy in 2026?
What is the fair value estimate for Axon Enterprise, Inc.?
Does Axon Enterprise, Inc. offer a margin of safety?
What are the main risks to the Axon Enterprise, Inc. thesis?
Research and opinion, not investment advice. Figures are as at the publication date above and are not maintained in real time.
Related Research
Don't have an eToro account yet? Open one here.
